BRIDGEBIO PHARMA INC

Ticker: BBIO CUSIP: 10806X102 Class: EQTY

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 13,771 Value ($000) $595 Avg Close $36.37 Range $28.32 - $45.48

Q1 2025

Shares 25,492 Value ($000) $881 Avg Close $33.72 Range $27.53 - $39.47

Q4 2024

Shares 61,118 Value ($000) $1,677 Avg Close $25.84 Range $21.72 - $30.51

Q3 2024

Shares 58,596 Value ($000) $1,492 Avg Close $26.25 Range $23.40 - $32.06

Q2 2024

Shares 36,500 Value ($000) $925 Avg Close $27.34 Range $21.62 - $31.43

Q4 2023

Shares 14,318 Value ($000) $578 Avg Close $30.03 Range $23.62 - $44.32

Q3 2023

Shares 57,300 Value ($000) $1,511 Avg Close $28.38 Range $16.61 - $36.36

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	13,771	$595	$36.37	$28.32 - $45.48
Q1 2025	25,492	$881	$33.72	$27.53 - $39.47
Q4 2024	61,118	$1,677	$25.84	$21.72 - $30.51
Q3 2024	58,596	$1,492	$26.25	$23.40 - $32.06
Q2 2024	36,500	$925	$27.34	$21.62 - $31.43
Q4 2023	14,318	$578	$30.03	$23.62 - $44.32
Q3 2023	57,300	$1,511	$28.38	$16.61 - $36.36